Terms: = Thyroid cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Clinical Outcome
10 results:
1. No Association of Preablation Thyroglobulin Antibody Positivity and outcome in Pediatric Patients With Papillary thyroid Carcinoma.
Xu Y; Shi L; Wu J; Li H; Wang Y; Liu B
Clin Nucl Med; 2023 Sep; 48(9):763-767. PubMed ID: 37385237
[TBL] [Abstract] [Full Text] [Related]
2. Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer.
Kim K; Pak K; Kim IJ; Kim M; Kim BH; Lee BJ; Kim SJ
Endocrine; 2020 Nov; 70(2):364-371. PubMed ID: 32372305
[TBL] [Abstract] [Full Text] [Related]
3. A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinoma.
Wong KS; Chen TY; Higgins SE; Howitt BE; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Histopathology; 2020 Apr; 76(5):707-713. PubMed ID: 31811787
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Significance of Extent of Invasion in Poorly Differentiated thyroid Carcinoma.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Thyroid; 2019 Sep; 29(9):1255-1261. PubMed ID: 31397224
[No Abstract] [Full Text] [Related]
5. Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
Premoli P; Tanda ML; Piantanida E; Veronesi G; Gallo D; Masiello E; Rosetti S; Cusini C; Boi F; Bulla J; Rodia R; Mariotti S; Capelli V; Rotondi M; Magri F; Chiovato L; Rocchi R; Campopiano MC; Elisei R; Vitti P; Barbato F; Pilli T; Castagna MG; Pacini F; Bartalena L
J Endocrinol Invest; 2020 Jan; 43(1):109-116. PubMed ID: 31327128
[TBL] [Abstract] [Full Text] [Related]
6. Risk factors for hypothyroidism in euthyroid thyroid nodule patients with lymphocytic thyroiditis on fine needle aspiration cytology.
Lee JM; Ha J; Jo K; Lim Y; Kim MH; Jung CK; Jung SL; Kang MI; Cha BY; Lim DJ
Korean J Intern Med; 2019 Nov; 34(6):1287-1296. PubMed ID: 29529842
[TBL] [Abstract] [Full Text] [Related]
7. The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature.
Grozinsky-Glasberg S; Bloom AI; Lev-Cohain N; Klimov A; Besiso H; Gross DJ
Eur J Endocrinol; 2017 Apr; 176(4):463-470. PubMed ID: 28100632
[TBL] [Abstract] [Full Text] [Related]
8. Improving prediction of malignancy of cytologically indeterminate thyroid nodules.
Tysome JR; Chandra A; Chang F; Puwanarajah P; Elliott M; Caroll P; Powrie J; Hubbard JG; Clarke SE; Jeannon JP; Simo R
Br J Surg; 2009 Dec; 96(12):1400-5. PubMed ID: 19918854
[TBL] [Abstract] [Full Text] [Related]
9. Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005.
Grozinsky-Glasberg S; Benbassat CA; Tsvetov G; Feinmesser R; Peretz H; Shimon I; Lapidot M
Thyroid; 2007 Jun; 17(6):549-56. PubMed ID: 17614776
[TBL] [Abstract] [Full Text] [Related]
10. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years.
Brignardello E; Gallo M; Baldi I; Palestini N; Piovesan A; Grossi E; Ciccone G; Boccuzzi G
Eur J Endocrinol; 2007 Apr; 156(4):425-30. PubMed ID: 17389456
[TBL] [Abstract] [Full Text] [Related]
